Jeffrey Hung

Stock Analyst at Morgan Stanley

(0)
# 4686
Out of 5,386 analysts
261
Total ratings
Success rate
Average return
42 Stocks
Name Action PT Current % Upside Ratings Updated
CGON CG Oncology
Maintains: Overweight
52 56
25.96 115.72% 4 Jun 17, 2025
ACAD ACADIA Pharmaceutica...
Maintains: Equal-Weight
20 24
22.09 8.65% 25 May 20, 2025
CTNM Contineum Therapeuti...
Maintains: Overweight
25 20
4.15 381.93% 3 May 19, 2025
RARE Ultragenyx Pharmaceu...
Maintains: Overweight
64 65
36.51 78.03% 8 May 9, 2025
JAZZ Jazz Pharmaceuticals
Maintains: Overweight
183 166
107.03 55.1% 6 May 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
15 17
7.23 135.13% 5 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
37 34
3.66 828.96% 3 Mar 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
72 72
62.59 15.03% 11 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
67 70
49.79 40.59% 11 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
185 150
125.44 19.58% 24 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
4 4
1.29 210.08% 3 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
85
54.48 56.02% 6 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
38 35
7.76 351.03% 6 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
27 27
13.14 105.48% 2 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Underweight
5
4.2 19.05% 2 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
70 67
33.16 102.05% 13 Feb 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
17 12
5.94 102.02% 4 Dec 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
92 95
n/a n/a 5 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
35
6.24 460.9% 1 Jul 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
50 70
29.82 134.74% 2 May 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
295 330
n/a n/a 3 Dec 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
10 4
0.81 393.83% 10 Dec 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
13 4
7.94 -49.62% 1 Dec 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Equal-Weight
1 4
0.74 440.54% 1 Dec 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Equal-Weight
60 140
n/a n/a 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
14 14
3.52 297.73% 3 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
5 5
2.7 85.19% 1 Jul 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
9 3
0.99 203.03% 8 Mar 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
15 14
1.39 907.19% 7 Feb 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
42 21
n/a n/a 4 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
4 2
n/a n/a 3 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
50 10
1.84 443.48% 3 Jan 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
22 30
n/a n/a 6 Jan 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
23 22
43.67 -49.62% 10 Nov 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
2 2
n/a n/a 5 Sep 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
250 94
n/a n/a 8 Jul 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
146 149
14.07 955.44% 2 May 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
180
n/a n/a 12 Oct 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
100 60
1.68 3471.43% 5 Aug 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
7 6
2.96 102.7% 9 Apr 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
121 225
n/a n/a 9 Oct 6, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
58 54
n/a n/a 6 May 8, 2020